Adalimumab (Tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina
- Fernandez-Bueno, I.
- Garcia-Gutierrez, M.T.
- Srivastava, G.K.
- Gayoso, M.J.
- Gonzalo-Orden, J.M.
- Pastor, J.C.
Revista:
Molecular Vision
ISSN: 1090-0535
Año de publicación: 2013
Volumen: 19
Páginas: 894-903
Tipo: Artículo